GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Dividend Payout Ratio

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Dividend Payout Ratio : 0.00 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio?

Chengdu Easton Biopharmaceuticals Co's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:688513' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26   Med: 0.43   Max: 0.57
Current: 0.29


During the past 8 years, the highest Dividend Payout Ratio of Chengdu Easton Biopharmaceuticals Co was 0.57. The lowest was 0.26. And the median was 0.43.

SHSE:688513's Dividend Payout Ratio is ranked better than
62.5% of 128 companies
in the Biotechnology industry
Industry Median: 0.435 vs SHSE:688513: 0.29

As of today (2024-05-26), the Dividend Yield % of Chengdu Easton Biopharmaceuticals Co is 0.99%.

During the past 8 years, the highest Trailing Annual Dividend Yield of Chengdu Easton Biopharmaceuticals Co was 1.53%. The lowest was 0.54%. And the median was 1.03%.

Chengdu Easton Biopharmaceuticals Co's Dividends per Share for the months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Chengdu Easton Biopharmaceuticals Co's average Dividends Per Share Growth Rate was -28.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Chart

Chengdu Easton Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial - - 0.26 0.57 0.43

Chengdu Easton Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.02 - - -

Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio falls into.



Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.56/ 1.31
=0.43

Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.625
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines